246 related articles for article (PubMed ID: 1469058)
1. Molecular isoforms of murine CD44 and evidence that the membrane proximal domain is not critical for hyaluronate recognition.
He Q; Lesley J; Hyman R; Ishihara K; Kincade PW
J Cell Biol; 1992 Dec; 119(6):1711-9. PubMed ID: 1469058
[TBL] [Abstract][Full Text] [Related]
2. Requirements for hyaluronic acid binding by CD44: a role for the cytoplasmic domain and activation by antibody.
Lesley J; He Q; Miyake K; Hamann A; Hyman R; Kincade PW
J Exp Med; 1992 Jan; 175(1):257-66. PubMed ID: 1730918
[TBL] [Abstract][Full Text] [Related]
3. Interaction of CD44 variant isoforms with hyaluronic acid and the cytoskeleton in human prostate cancer cells.
Welsh CF; Zhu D; Bourguignon LY
J Cell Physiol; 1995 Sep; 164(3):605-12. PubMed ID: 7544357
[TBL] [Abstract][Full Text] [Related]
4. Ankyrin-binding domain of CD44(GP85) is required for the expression of hyaluronic acid-mediated adhesion function.
Lokeshwar VB; Fregien N; Bourguignon LY
J Cell Biol; 1994 Aug; 126(4):1099-109. PubMed ID: 7519619
[TBL] [Abstract][Full Text] [Related]
5. Regulation of human CD44H and CD44E isoform binding to hyaluronan by phorbol myristate acetate and anti-CD44 monoclonal and polyclonal antibodies.
Liao HX; Levesque MC; Patton K; Bergamo B; Jones D; Moody MA; Telen MJ; Haynes BF
J Immunol; 1993 Dec; 151(11):6490-9. PubMed ID: 7504022
[TBL] [Abstract][Full Text] [Related]
6. CD44 expression on activated B cells. Differential capacity for CD44-dependent binding to hyaluronic acid.
Hathcock KS; Hirano H; Murakami S; Hodes RJ
J Immunol; 1993 Dec; 151(12):6712-22. PubMed ID: 7505013
[TBL] [Abstract][Full Text] [Related]
7. Glycosylation of CD44 negatively regulates its recognition of hyaluronan.
Katoh S; Zheng Z; Oritani K; Shimozato T; Kincade PW
J Exp Med; 1995 Aug; 182(2):419-29. PubMed ID: 7543137
[TBL] [Abstract][Full Text] [Related]
8. Glycosylation of CD44 is implicated in CD44-mediated cell adhesion to hyaluronan.
Bartolazzi A; Nocks A; Aruffo A; Spring F; Stamenkovic I
J Cell Biol; 1996 Mar; 132(6):1199-208. PubMed ID: 8601595
[TBL] [Abstract][Full Text] [Related]
9. Defective phosphorylation and hyaluronate binding of CD44 with point mutations in the cytoplasmic domain.
Puré E; Camp RL; Peritt D; Panettieri RA; Lazaar AL; Nayak S
J Exp Med; 1995 Jan; 181(1):55-62. PubMed ID: 7528778
[TBL] [Abstract][Full Text] [Related]
10. CD44: structure, function, and association with the malignant process.
Naor D; Sionov RV; Ish-Shalom D
Adv Cancer Res; 1997; 71():241-319. PubMed ID: 9111868
[TBL] [Abstract][Full Text] [Related]
11. Binding of cell-surface expressed CD44 to hyaluronate is dependent on splicing and cell type.
van der Voort R; Manten-Horst E; Smit L; Ostermann E; van den Berg F; Pals ST
Biochem Biophys Res Commun; 1995 Sep; 214(1):137-44. PubMed ID: 7545390
[TBL] [Abstract][Full Text] [Related]
12. Ligand binding specificity of alternatively spliced CD44 isoforms. Recognition and binding of hyaluronan by CD44R1.
Dougherty GJ; Cooper DL; Memory JF; Chiu RK
J Biol Chem; 1994 Mar; 269(12):9074-8. PubMed ID: 7510702
[TBL] [Abstract][Full Text] [Related]
13. Hyaluronate-independent metastatic behavior of CD44 variant-expressing pancreatic carcinoma cells.
Sleeman JP; Arming S; Moll JF; Hekele A; Rudy W; Sherman LS; Kreil G; Ponta H; Herrlich P
Cancer Res; 1996 Jul; 56(13):3134-41. PubMed ID: 8674073
[TBL] [Abstract][Full Text] [Related]
14. Inducible binding of human lymphocytes to hyaluronate via CD44 does not require cytoskeleton association but does require new protein synthesis.
Murakami S; Shimabukuro Y; Miki Y; Saho T; Hino E; Kasai D; Nozaki T; Kusumoto Y; Okada H
J Immunol; 1994 Jan; 152(2):467-77. PubMed ID: 7506725
[TBL] [Abstract][Full Text] [Related]
15. Identification of hyaluronic acid binding sites in the extracellular domain of CD44.
Peach RJ; Hollenbaugh D; Stamenkovic I; Aruffo A
J Cell Biol; 1993 Jul; 122(1):257-64. PubMed ID: 8314845
[TBL] [Abstract][Full Text] [Related]
16. Molecular cloning of CD44R1 and CD44R2, two novel isoforms of the human CD44 lymphocyte "homing" receptor expressed by hemopoietic cells.
Dougherty GJ; Landorp PM; Cooper DL; Humphries RK
J Exp Med; 1991 Jul; 174(1):1-5. PubMed ID: 2056274
[TBL] [Abstract][Full Text] [Related]
17. Hyaluronate can function as a cell adhesion molecule and CD44 participates in hyaluronate recognition.
Miyake K; Underhill CB; Lesley J; Kincade PW
J Exp Med; 1990 Jul; 172(1):69-75. PubMed ID: 2193100
[TBL] [Abstract][Full Text] [Related]
18. CD44H regulates tumor cell migration on hyaluronate-coated substrate.
Thomas L; Byers HR; Vink J; Stamenkovic I
J Cell Biol; 1992 Aug; 118(4):971-7. PubMed ID: 1380003
[TBL] [Abstract][Full Text] [Related]
19. Proteoglycan forms of the lymphocyte homing receptor CD44 are alternatively spliced variants containing the v3 exon.
Jackson DG; Bell JI; Dickinson R; Timans J; Shields J; Whittle N
J Cell Biol; 1995 Feb; 128(4):673-85. PubMed ID: 7532175
[TBL] [Abstract][Full Text] [Related]
20. Variant cell lines selected for alterations in the function of the hyaluronan receptor CD44 show differences in glycosylation.
Lesley J; English N; Perschl A; Gregoroff J; Hyman R
J Exp Med; 1995 Aug; 182(2):431-7. PubMed ID: 7543138
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
